Modern technologies in diabetology. CSII (Continuous Subcutaneous Insulin Infusion) and CGM (Continuous Glucose Monitoring) in clinical practice

Česká verzia

Authors: J. Olšovský
Authors place of work: Diabetologické centrum II. interní kliniky Lékařské fakulty MU a FN u sv. Anny Brno, přednosta prof. MUDr. Miroslav Souček, CSc.
Published in the journal: Vnitř Lék 2011; 57(11): 919-922
Category: Birthday

Summary

Modern diabetology is closely associated with the use of modern technologies; glucometres are now widely clinically used and it is difficult to envisage diabetology without these devices. At present, CSII and CGM are less frequently used but they certainly are equally exciting. The author discusses both methods individually as well their interrelationship, mainly from the perspective of their optimal use.

Key words:
diabetes mellitus – continuous subcutaneous insulin infusion – continuous glucose monitoring

Zdroje

1. Pickup JC, Keen H, Parsons JA et al. Continuous subcutaneous insulin infusion: an aproach to achieving normoglycemia. Br Med J 1978; 1: 204–207.

2. Pickup J, Keen H. Continuous subcutaneous insulin infusion et 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes. Diabetes Care 2002; 25: 593–598.

3. Olšovský J. Inzulínová pumpa. In: Perušičová J et al (eds). Trendy soudobé diabetologie. sv. 9. Praha: Galén 2004: 49–71.

4. Brož J, Kožnarová R, Bartášková D et al. Současné možnosti léčby diabetes mellitus pomocí inzulínových pump. XLII. Diabetologické dny, Luhačovice, 20.–22. 4. 2006. Diabetologie, Metabolismus, Endokrynologie, Výživa 2006; 4: 179–186.

5. Jankovec Z, Krčma M, Lacigová S et al. Registr pacientů léčených inzulínovou pumpou v České republice. XLII. Diabetologické dny, Luhačovice, 20.–22. 4. 2006. Diabetologie, Metabolismus, Endokrynologie, Výživa 2004; Suppl 1: 22.

6. Jankovec Z, Čechurová D, Krčma M et al. Dlouhodobý efekt léčby inzulínovou pumpou (CSII) – výsledky registru pacientů léčených CSII v České republice. XLII. Diabetologické dny, Luhačovice, 20.–22. 4. 2006. Diabetologie, Metabolismus, Endokrynologie, Výživa 2006; Suppl 2: 26.

7. Markus AO. Patient selection for insulin pump therapy. Practical Diabetology Nov 1992; 14: 12–18.

8. Jornsay DL, Duckles AE, Hankinson JP. Psychological considerations for patient selection and adjustment to insulin pump therapy. Diabetes Educ 1988; 14: 291–296.

9. Olšovský J, Beránek M. Vliv dlouhodobé terapie inzulínovou pumpou (CSII) u pacientů s diabetes mellitus 1. typu na metabolickou kompenzaci a výskyt hypoglykemií. Porovnání s intenzifikovanou konvenční inzulinovou terapií. Vnitř Lék 2007; 6: 637–645.

10. Mecklenburg RS, Benson EA, Ben-son JW Jr et al. Acute complications associated with insulin infusion pump therapy. Report of experience with 161 patients. JAMA 1984: 252: 3265–3269.

11. Bending J, Pickup JC, Keen H. The frequency of diabetic ketoacidosis and hypoglycemic coma during treatment with continuous subcutaneous insulin infusion. Audit of medical care. Am J Med 1985; 79: 685–691.